Researchers in Taiwan have developed a new targeted therapy drug that preclinical trials suggest could inhibit the growth of tumors in nearly 30 percent of cancer patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Ko Wen-je has operation to remove kidney stone
04/02/2025 01:40 PM - Politics
U.S., EU voice opposition to Taiwan Strait status quo change amid PLA drills
04/02/2025 11:46 AM - Cross-Strait
95 PLA aircraft, vessels detected near Taiwan during drill Tuesday
04/02/2025 11:24 AM - Cross-Strait
PLA military drills in Taiwan Strait enter 2nd day
04/02/2025 11:01 AM - Business
U.S. dollar up in Taipei trading
04/02/2025 10:12 AM